Neuroscientific Biopharmaceuticals Ltd
Talk to Neuroscientific Biopharmaceuticals Ltd directly.
Sign up to their Investor Hub for direct access to the Neuroscientific Biopharmaceuticals Ltd team, ask them questions, and see personal updates.
NeuroScientific Biopharmaceuticals Ltd (NSB) is developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's current R&D program is focused on developing a treatment for stroke-related brain injury and dementia / Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The Company's lead drug candidate, EmtinB, is a treatment for Alzheimer's disease. The Company also holds patents over 15mS.A., which has several novel capabilities that have the potential to translate into diagnostic processes for Alzheimer's Disease.
Level 1/45 Stirling Hwy, Nedlands WA 6009, Australia
Earnings per share
Dividend per share